Biogen Inc to Acquire Reata Pharmaceuticals Inc Call Transcript
Good morning. My name is Marjorie, and I will be your conference operator today. At this time, I'd like to welcome everyone to the Biogen business update. (Operator Instructions) Today's conference is being recorded. I would now like to turn the conference over to Mr. Chuck Triano, Head of Investor Relations. Mr. Triano, you may begin your conference.
Thanks, Marjorie. Good morning, everyone, and thank you for joining us on short notice this morning. We know we're still busy in earnings season, and we will keep this call to about 30 minutes. During this call, we will be making forward-looking statements, which are based on our expectations. These statements are subject to certain risks and uncertainties and our actual results may differ materially. I encourage you to consult the risk factors discussed in our SEC filings for additional detail.
On today's call, I am joined by our President and Chief Executive Officer, Chris Viehbacher, and CFO, Mike McDonnell. Chris and Mike will each make some
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |